載入...
siRNA Therapeutics against Respiratory Viral Infections—What Have We Learned for Potential COVID‐19 Therapies?
Acute viral respiratory tract infections (AVRIs) are a major burden on human health and global economy and amongst the top five causes of death worldwide resulting in an estimated 3.9 million lives lost every year. In addition, new emerging respiratory viruses regularly cause outbreaks such as SARS‐...
Na minha lista:
| 發表在: | Adv Healthc Mater |
|---|---|
| Main Authors: | , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2021
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7995229/ https://ncbi.nlm.nih.gov/pubmed/33506607 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/adhm.202001650 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|